Health officials say that seasonal flu vaccines are arriving early and in plentiful supply this fall. And they hope that a record 115 million doses in the U.S. will avoid the shortfalls that have bedeviled the country for years.
- here's the article [1] on flu vaccines from The New York Times
ALSO: One reason for the optimism was yesterday's announcement that the FDA has approved GlaxoSmithKline's FluLaval. Report [2]
Links:
[1] http://www.nytimes.com/2006/10/06/us/06flu.html?ref=health
[2] http://www.lse.co.uk/FinanceNews.asp?shareprice=&ArticleRef=65323&ArticleHeadline=GSKs_Flulaval_approved_by_FDA_for_immunization_of_adults_against_flu